Notice of Meeting, 44537-44538 [2020-15936]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 142 / Thursday, July 23, 2020 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
Agency for Healthcare Research and
Quality
[FR Doc. 2020–15933 Filed 7–22–20; 8:45 am]
BILLING CODE 4160–90–P
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
ACTION:
Notice.
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘HSQR ZHS1 HSR X–
(02).’’ This SEP meeting will be closed
to the public.
SUMMARY:
DATES:
August 19, 2020.
Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301) 427–1557.
A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the AHRQ, and agree
to be available, to conduct on an as
needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not
attend regularly-scheduled meetings
and do not serve for fixed terms or a
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘AHRQ–HSQR ZHS1 HSR X–(02).’’ are
to be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
jbell on DSKJLSW7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:10 Jul 22, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
44537
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Agency for Healthcare Research and
Quality
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
Notice of Meeting
[FR Doc. 2020–15932 Filed 7–22–20; 8:45 am]
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘AHRQ RFAHS20–
002 Supporting Primary Care to
Advance Cardiovascular Health in
States with High Prevalence of
Preventable CVD Events (U18).’’ This
SEP meeting will be closed to the
public.
SUMMARY:
August 25, 2020.
Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301) 427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by AHRQ, and agree to
be available, to conduct on an as needed
basis, scientific reviews of applications
for AHRQ support. Individual members
of the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘AHRQ RFAHS20–002 Supporting
Primary Care to Advance Cardiovascular
Health in States with High Prevalence of
Preventable CVD Events (U18).’’ are to
be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
DATES:
ADDRESSES:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘AHRQ RFAHS20–
003 Novel, High-Impact Studies
Evaluating Health System and
Healthcare Professional Responsiveness
to COVID–19 (R01).’’ This SEP meeting
will be closed to the public.
DATES: August 27–28, 2020.
ADDRESSES: Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850. Telephone:
(301)427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the AHRQ, and agree
to be available, to conduct on an as
needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not
attend regularly-scheduled meetings
and do not serve for fixed terms or a
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
SUMMARY:
E:\FR\FM\23JYN1.SGM
23JYN1
44538
Federal Register / Vol. 85, No. 142 / Thursday, July 23, 2020 / Notices
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘AHRQ RFAHS20–003 Novel, HighImpact Studies Evaluating Health
System and Healthcare Professional
Responsiveness to COVID–19 (R01).’’
are to be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
particular review meetings which
require their type of expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘HCRT SEP 2020/10 ZHS1 HSR A (01).’’
are to be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–15936 Filed 7–22–20; 8:45 am]
BILLING CODE 4160–90–P
[FR Doc. 2020–15935 Filed 7–22–20; 8:45 am]
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘HCRT SEP 2020/10
ZHS1 HSR A (01).’’ This SEP meeting
will be closed to the public.
DATES: August 14, 2020.
ADDRESSES: Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301) 427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by AHRQ, and agree to
be available, to conduct on an as needed
basis, scientific reviews of applications
for AHRQ support. Individual members
of the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:10 Jul 22, 2020
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Jkt 250001
Notice of Meeting
Agency for Healthcare Research
and Quality, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘HSQR ZHS1 HSR X(01).’’ This SEP meeting will be closed
to the public.
DATES: August 19, 2020.
ADDRESSES: Agency for Healthcare
Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301) 427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the AHRQ, and agree
to be available, to conduct on an as
needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not
SUMMARY:
PO 00000
Frm 00040
Fmt 4703
attend regularly-scheduled meetings
and do not serve for fixed terms or a
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘AHRQ-HSQR ZHS1 HSR X-(01).’’ are
to be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy. Agenda
items for this meeting are subject to
change as priorities dictate.
Sfmt 4703
[FR Doc. 2020–15934 Filed 7–22–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics
(NCHS), ICD–10 Coordination and
Maintenance (C&M) Committee
Meeting
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The CDC, National Center for
Health Statistics (NCHS), Classifications
and Public Health Data Standards Staff,
announces the following meeting of the
ICD–10 Coordination and Maintenance
(C&M) Committee meeting. This
meeting is open to the public, limited
only by audio and web conferences
lines available. Online Registration is
not required.
DATES: The meeting will be held on
September 8, 2020, from 9:00 a.m. to
5:00 p.m., EDT, and September 9, 2020,
from 9:00 a.m. to 5:00 p.m., EDT.
ADDRESSES: This is a virtual meeting.
Information will be provided on each of
our respective web pages when it
becomes available. For CDC/NCHS
https://www.cdc.gov/nchs/icd/icd10cm_
maintenance.htm.
SUMMARY:
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 85, Number 142 (Thursday, July 23, 2020)]
[Notices]
[Pages 44537-44538]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15936]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ)
announces a Special Emphasis Panel (SEP) meeting on ``AHRQ RFAHS20-003
Novel, High-Impact Studies Evaluating Health System and Healthcare
Professional Responsiveness to COVID-19 (R01).'' This SEP meeting will
be closed to the public.
DATES: August 27-28, 2020.
ADDRESSES: Agency for Healthcare Research and Quality, (Video Assisted
Review), 5600 Fishers Lane, Rockville, Maryland 20850.
FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management
Officer, Office of Extramural Research, Education and Priority
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600
Fishers Lane, Rockville, Maryland 20850. Telephone: (301)427-1557.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
the AHRQ, and agree to be available, to conduct on an as needed basis,
scientific reviews of applications for AHRQ support. Individual members
of the Panel do not attend regularly-scheduled meetings and do not
serve for fixed terms or a long period of time. Rather, they are asked
to participate in particular review meetings which require their type
of expertise.
The SEP meeting referenced above will be closed to the public in
accordance with the provisions set forth
[[Page 44538]]
in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the ``AHRQ RFAHS20-003 Novel, High-
Impact Studies Evaluating Health System and Healthcare Professional
Responsiveness to COVID-19 (R01).'' are to be reviewed and discussed at
this meeting. The grant applications and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the grant applications, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: July 17, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-15936 Filed 7-22-20; 8:45 am]
BILLING CODE 4160-90-P
